AMNEAL PHARMACEUTICALS, INC. (AMRX) Total assets 2017–2025
AMNEAL PHARMACEUTICALS, INC. (AMRX) total assets at each fiscal year-end, per SEC filings.
$3.7BFY2025 · since FY2017: $1.3B → $3.7B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.7B | +5.1% |
| FY2024 | $3.5B | +0.8% |
| FY2023 | $3.5B | -8.6% |
| FY2022 | $3.8B | -3.6% |
| FY2021 | $3.9B | -1.7% |
| FY2020 | $4.0B | +9.3% |
| FY2019 | $3.7B | -15.8% |
| FY2018 | $4.4B | +224.4% |
| FY2017 | $1.3B | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AMRX financial trends
AMRX RevenueAMRX Net incomeAMRX Net marginAMRX Gross profitAMRX Gross marginAMRX Operating incomeAMRX Operating marginAMRX Operating cash flowAMRX Free cash flowAMRX Capital expendituresAMRX Return on equityAMRX Stock buybacksAMRX Dividends paidAMRX Total liabilitiesAMRX Shareholders’ equityAMRX overview →